Health insurer Aetna Inc. (NYSE: AET) will cover Vivus Inc.'s (Nasdaq: VVUS) obesity treatment Qsymia. Shares of Aetna rose 38 cents to $42.22 while Vivus stock leaped $1.30 to $11.65.
Aetna Covers Vivus' Qsymia
November 21, 2012 at 11:40 AM EST
